Dasatinib promotes the expansion of a therapeutically superior T-cell repertoire in response to dendritic cell vaccination against melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-02-27 / Oncoimmunology 2014 Jan;3(1):e27589DNA fragmentation and caspase-independent programmed cell death by modulated electrohyperthermia
/in Hyperthermia, International Publications /von 2014-02-22 / Strahlenther Onkol 2014 Sep;190(9):815-22Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response
/in Dendritic Cells, Glioblastoma, International Publications /von 2014-02-18 / J Immunother Cancer 2014;2:4Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2014-02-05 / Cancer Immunol Res 2014 May;2(5):404-9Immunotherapy prospects in the treatment of lung cancer and mesothelioma
/in International Publications, Malignant Pleural Mesothelioma, NSCLC, SCLC /von 2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):34-45Fighting fire with fire: the revival of thermotherapy for gliomas
/in Glioblastoma, Hyperthermia, International Publications /von 2014-02-01 / Anticancer Res. 2014 Feb;34(2):565-74Immunotherapy in lung cancer
/in International Publications, NSCLC, SCLC /von 2014-02-01 / Transl Lung Cancer Res 2014 Feb;3(1):53-63
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de